T2 Biosystems Stock Price, News & Analysis (NASDAQ:TTOO)

$4.42 -0.04 (-0.90 %)
(As of 02/22/2018 02:13 PM ET)
Previous Close$4.42
Today's Range$4.37 - $4.64
52-Week Range$2.50 - $6.99
Volume106,300 shs
Average Volume227,757 shs
Market Capitalization$159.78 million
P/E RatioN/A
Dividend YieldN/A
Beta1.71

About T2 Biosystems (NASDAQ:TTOO)

T2 Biosystems logoT2 Biosystems, Inc. is an in vitro diagnostics company engaged in developing a technology platform offering an alternative to diagnostic methodologies. The Company's T2 Magnetic Resonance platform (T2MR) enables detection of pathogens, biomarkers and other abnormalities in a range of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as one colony forming unit per milliliter (CFU/mL). The Company's initial development efforts target sepsis, hemostasis and Lyme disease. T2MR is a miniaturized, magnetic resonance-based approach that measures how water molecules react in the presence of magnetic fields. Its platform detects a range of targets, including molecular targets, such as deoxyribonucleic acid (DNA), immunodiagnostics, such as proteins, and a range of hemostasis measurements. The Company offers T2Dx Instrument (T2Dx) and the T2Candida Panel.

Receive TTOO News and Ratings via Email

Sign-up to receive the latest news and ratings for TTOO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:TTOO
CUSIPN/A
Phone781-761-4646

Debt

Debt-to-Equity Ratio2.25%
Current Ratio5.40%
Quick Ratio5.28%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$4.10 million
Price / Sales38.63
Cash FlowN/A
Price / CashN/A
Book Value$1.29 per share
Price / Book3.43

Profitability

Trailing EPS($1.90)
Net Income$-54,800,000.00
Net Margins-1,497.70%
Return on Equity-244.82%
Return on Assets-78.53%

Miscellaneous

Employees178
Outstanding Shares35,830,000

T2 Biosystems (NASDAQ:TTOO) Frequently Asked Questions

What is T2 Biosystems' stock symbol?

T2 Biosystems trades on the NASDAQ under the ticker symbol "TTOO."

How were T2 Biosystems' earnings last quarter?

T2 Biosystems Inc (NASDAQ:TTOO) released its quarterly earnings results on Thursday, November, 2nd. The medical equipment provider reported ($0.45) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.49) by $0.04. The medical equipment provider earned $1.11 million during the quarter, compared to the consensus estimate of $1.10 million. T2 Biosystems had a negative return on equity of 244.82% and a negative net margin of 1,497.70%. T2 Biosystems's quarterly revenue was up 2.8% on a year-over-year basis. View T2 Biosystems' Earnings History.

Where is T2 Biosystems' stock going? Where will T2 Biosystems' stock price be in 2018?

6 brokers have issued 1 year price objectives for T2 Biosystems' shares. Their predictions range from $4.00 to $8.00. On average, they expect T2 Biosystems' stock price to reach $5.70 in the next twelve months. View Analyst Ratings for T2 Biosystems.

Who are some of T2 Biosystems' key competitors?

Who are T2 Biosystems' key executives?

T2 Biosystems' management team includes the folowing people:

  • John McDonough, President, Chief Executive Officer, Director (Age 57)
  • Michael J. Cima Ph.D., Co-Founder, Independent Director (Age 57)
  • John Sprague, Chief Financial Officer
  • Joanne Spadoro Ph.D., Chief Operations Officer (Age 58)
  • Rahul K. Dhanda, Senior Vice President - Corporate Development (Age 44)
  • Thomas J. Lowery Ph.D., Chief Scientific Officer (Age 38)
  • Michael Gibbs, Vice President, General Counsel (Age 46)
  • Michael A. Pfaller M.D., Chief Medical Officer (Age 66)
  • Seymour E. Liebman, Director (Age 68)
  • John W. Cumming, Independent Director (Age 71)

Who owns T2 Biosystems stock?

T2 Biosystems' stock is owned by many different of retail and institutional investors. Top institutional investors include Essex Investment Management Co. LLC (1.91%), Fuller & Thaler Asset Management Inc. (1.14%), Millennium Management LLC (0.38%), Geode Capital Management LLC (0.38%), Renaissance Technologies LLC (0.23%) and Gagnon Securities LLC (0.19%). Company insiders that own T2 Biosystems stock include Darlene M Deptula-Hicks, David B Elsbree, Joanne Spadoro, Michael Terrence Gibbs and Rahul Dhanda. View Institutional Ownership Trends for T2 Biosystems.

Who sold T2 Biosystems stock? Who is selling T2 Biosystems stock?

T2 Biosystems' stock was sold by a variety of institutional investors in the last quarter, including Fuller & Thaler Asset Management Inc., Millennium Management LLC, Gagnon Securities LLC and Essex Investment Management Co. LLC. View Insider Buying and Selling for T2 Biosystems.

Who bought T2 Biosystems stock? Who is buying T2 Biosystems stock?

T2 Biosystems' stock was purchased by a variety of institutional investors in the last quarter, including Geode Capital Management LLC and Renaissance Technologies LLC. Company insiders that have bought T2 Biosystems stock in the last two years include Darlene M Deptula-Hicks, David B Elsbree, Joanne Spadoro and Michael Terrence Gibbs. View Insider Buying and Selling for T2 Biosystems.

How do I buy T2 Biosystems stock?

Shares of T2 Biosystems can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is T2 Biosystems' stock price today?

One share of T2 Biosystems stock can currently be purchased for approximately $4.42.

How big of a company is T2 Biosystems?

T2 Biosystems has a market capitalization of $159.78 million and generates $4.10 million in revenue each year. The medical equipment provider earns $-54,800,000.00 in net income (profit) each year or ($1.90) on an earnings per share basis. T2 Biosystems employs 178 workers across the globe.

How can I contact T2 Biosystems?

T2 Biosystems' mailing address is 101 HARTWELL AVENUE, LEXINGTON MA, 02421. The medical equipment provider can be reached via phone at 781-761-4646 or via email at [email protected]


MarketBeat Community Rating for T2 Biosystems (TTOO)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  180 (Vote Outperform)
Underperform Votes:  156 (Vote Underperform)
Total Votes:  336
MarketBeat's community ratings are surveys of what our community members think about T2 Biosystems and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

T2 Biosystems (NASDAQ:TTOO) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldBuyBuyHold
Consensus Rating Score: 2.332.502.502.33
Ratings Breakdown: 1 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $5.70$6.83$6.83$6.83
Price Target Upside: 33.18% upside79.82% upside79.82% upside71.69% upside

T2 Biosystems (NASDAQ:TTOO) Consensus Price Target History

Price Target History for T2 Biosystems (NASDAQ:TTOO)

T2 Biosystems (NASDAQ:TTOO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/12/2018HC WainwrightSet Price TargetBuy$8.00LowView Rating Details
1/29/2018Goldman Sachs GroupInitiated CoverageNeutral -> Neutral$5.20HighView Rating Details
10/30/2017Canaccord GenuityReiterated RatingBuy$6.00N/AView Rating Details
5/8/2017BTIG ResearchUpgradeSell -> Neutral$4.00HighView Rating Details
5/3/2017Cantor FitzgeraldLower Price TargetOverweight$7.00 -> $6.00HighView Rating Details
3/14/2017Morgan StanleyDowngradeEqual Weight -> Underweight$5.00HighView Rating Details
2/5/2017WBB SecuritiesReiterated RatingBuy$12.00N/AView Rating Details
11/10/2016Leerink SwannReiterated RatingMarket Perform$5.00N/AView Rating Details
7/9/2016Janney Montgomery ScottReiterated RatingHoldN/AView Rating Details
(Data available from 2/22/2016 forward)

Earnings

T2 Biosystems (NASDAQ:TTOO) Earnings History and Estimates Chart

Earnings by Quarter for T2 Biosystems (NASDAQ:TTOO)

T2 Biosystems (NASDAQ TTOO) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2017Q3 2017($0.49)($0.45)$1.10 million$1.11 millionViewN/AView Earnings Details
8/3/2017Q2 2017($0.49)($0.50)$0.79 million$0.96 millionViewListenView Earnings Details
5/2/2017Q1 2017($0.47)($0.48)$1.55 million$0.94 millionViewListenView Earnings Details
2/16/2017Q4 2016($0.45)($0.47)$1.23 million$0.91 millionViewN/AView Earnings Details
11/1/2016Q3($0.52)($0.51)$2.03 million$1.08 millionViewN/AView Earnings Details
8/1/2016Q2($0.56)($0.58)$1.53 million$0.99 millionViewN/AView Earnings Details
5/2/2016Q1($0.54)($0.55)$1.01 million$1.10 millionViewN/AView Earnings Details
2/16/2016Q4($0.59)($0.56)$1.21 million$1.01 millionViewListenView Earnings Details
11/2/2015Q3($0.59)($0.57)$0.66 million$1.05 millionViewN/AView Earnings Details
8/4/2015Q215($0.57)($0.54)$0.34 million$0.56 millionViewN/AView Earnings Details
5/5/2015Q115($0.57)($0.53)$0.22 million$0.19 millionViewN/AView Earnings Details
2/17/2015Q414($0.44)($0.45)$0.12 millionViewN/AView Earnings Details
11/4/2014Q314($0.58)($0.71)$0.10 millionViewN/AView Earnings Details
9/19/2014Q2 2014($6.35)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

T2 Biosystems (NASDAQ:TTOO) Earnings Estimates

2018 EPS Consensus Estimate: ($1.96)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.53)($0.53)($0.53)
Q2 20181($0.50)($0.50)($0.50)
Q3 20181($0.48)($0.48)($0.48)
Q4 20181($0.45)($0.45)($0.45)
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for T2 Biosystems (NASDAQ:TTOO)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

T2 Biosystems (NASDAQ TTOO) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 38.70%
Institutional Ownership Percentage: 59.67%
Insider Trades by Quarter for T2 Biosystems (NASDAQ:TTOO)
Institutional Ownership by Quarter for T2 Biosystems (NASDAQ:TTOO)

T2 Biosystems (NASDAQ TTOO) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/16/2017David B ElsbreeDirectorBuy1,500$4.11$6,165.00View SEC Filing  
6/6/2017Darlene M Deptula-HicksCFOBuy4,000$3.58$14,320.004,000View SEC Filing  
6/6/2017David B ElsbreeDirectorBuy10,000$3.50$35,000.0050,000View SEC Filing  
6/6/2017Joanne SpadoroCOOBuy5,000$3.50$17,500.00View SEC Filing  
6/6/2017Michael Terrence GibbsGeneral CounselBuy1,000$3.51$3,510.00View SEC Filing  
3/15/2017David B ElsbreeDirectorBuy10,000$5.97$59,700.0040,000View SEC Filing  
6/30/2016Rahul DhandaSVPSell3,589$8.16$29,286.243,589View SEC Filing  
3/16/2016Rahul DhandaSVPSell7,588$8.01$60,779.884,647View SEC Filing  
12/9/2015Aisling Capital Iii LpMajor ShareholderBuy307,692$9.75$2,999,997.00View SEC Filing  
12/9/2015David B ElsbreeDirectorBuy10,000$9.75$97,500.0030,000View SEC Filing  
7/24/2015Polaris Venture Partners V, L.Major ShareholderSell15,399$15.04$231,600.96View SEC Filing  
7/22/2015Polaris Venture Partners V, L.Major ShareholderSell14,999$15.22$228,284.78View SEC Filing  
7/21/2015Polaris Venture Partners V, L.Major ShareholderSell14,999$15.42$231,284.58View SEC Filing  
7/20/2015Polaris Venture Partners V, L.Major ShareholderSell14,999$16.05$240,733.95View SEC Filing  
7/17/2015Polaris Venture Partners V, L.Major ShareholderSell44,997$16.26$731,651.22View SEC Filing  
7/14/2015Polaris Venture Partners V, L.Major ShareholderSell29,998$16.57$497,066.86View SEC Filing  
7/10/2015Polaris Venture Partners V, L.Major ShareholderSell44,997$16.25$731,201.25View SEC Filing  
7/10/2015Thomas J LoweryInsiderSell2,000$16.03$32,060.00View SEC Filing  
7/7/2015Polaris Venture Partners V, L.Major ShareholderSell44,997$15.91$715,902.27View SEC Filing  
7/1/2015Polaris Venture Partners V, L.Major ShareholderSell44,997$16.09$724,001.73View SEC Filing  
6/30/2015Polaris Venture Partners V, L.Major ShareholderSell14,999$16.22$243,283.78View SEC Filing  
6/29/2015Polaris Venture Partners V, L.Major ShareholderSell14,999$16.28$244,183.72View SEC Filing  
6/26/2015Polaris Venture Partners V, L.Major ShareholderSell44,997$17.08$768,548.76View SEC Filing  
6/23/2015Polaris Venture Partners V, L.Major ShareholderSell29,998$18.18$545,363.64View SEC Filing  
6/22/2015Polaris Venture Partners V, L.Major ShareholderSell14,999$18.22$273,281.78View SEC Filing  
6/18/2015Thomas J LoweryInsiderSell1,000$18.65$18,650.00View SEC Filing  
6/12/2015Michael J CimaDirectorBuy1,000$18.91$18,910.00View SEC Filing  
6/12/2015Thomas J LoweryInsiderSell1,471$18.55$27,287.05View SEC Filing  
5/8/2015Michael A PfallerInsiderSell15,440$16.31$251,826.40View SEC Filing  
4/20/2015Thomas J LoweryInsiderSell1,000$18.43$18,430.00View SEC Filing  
3/4/2015David B ElsbreeDirectorBuy1,450$15.05$21,822.50View SEC Filing  
11/13/2014David B ElsbreeDirectorBuy1,500$14.75$22,125.00View SEC Filing  
8/12/2014Aisling Capital Iii LpMajor ShareholderBuy454,545$11.00$4,999,995.00View SEC Filing  
8/12/2014Sarah O KalilCOOBuy15,000$11.00$165,000.00View SEC Filing  
8/12/2014Thomas J CarellaDirectorBuy909,090$11.00$9,999,990.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

T2 Biosystems (NASDAQ TTOO) News Headlines

Source:
DateHeadline
T2 Biosystems Announces 2017 Fourth Quarter and Full-Year Financial and Operational Results Release and Conference Call DateT2 Biosystems Announces 2017 Fourth Quarter and Full-Year Financial and Operational Results Release and Conference Call Date
finance.yahoo.com - February 20 at 8:13 AM
T2 Biosystems (TTOO) PT Set at $8.00 by HC WainwrightT2 Biosystems (TTOO) PT Set at $8.00 by HC Wainwright
www.americanbankingnews.com - February 12 at 6:34 PM
Two New Studies Demonstrate T2Candida’s Advantages over Current Diagnostic TestingTwo New Studies Demonstrate T2Candida’s Advantages over Current Diagnostic Testing
finance.yahoo.com - February 9 at 9:32 AM
 Analysts Anticipate T2 Biosystems Inc (TTOO) Will Post Quarterly Sales of $1.20 Million Analysts Anticipate T2 Biosystems Inc (TTOO) Will Post Quarterly Sales of $1.20 Million
www.americanbankingnews.com - February 7 at 12:01 PM
T2 Biosystems Announces CFO TransitionT2 Biosystems Announces CFO Transition
finance.yahoo.com - February 6 at 9:07 AM
T2 Biosystems to Present at the 7th Annual Leerink Partners Global Healthcare ConferenceT2 Biosystems to Present at the 7th Annual Leerink Partners Global Healthcare Conference
finance.yahoo.com - February 6 at 9:07 AM
T2 Biosystems (TTOO) Set to Announce Earnings on MondayT2 Biosystems (TTOO) Set to Announce Earnings on Monday
www.americanbankingnews.com - February 5 at 4:00 AM
 Brokerages Expect T2 Biosystems Inc (TTOO) Will Post Earnings of -$0.42 Per Share Brokerages Expect T2 Biosystems Inc (TTOO) Will Post Earnings of -$0.42 Per Share
www.americanbankingnews.com - February 5 at 3:12 AM
T2 Biosystems Inc (TTOO) Given Consensus Recommendation of "Hold" by BrokeragesT2 Biosystems Inc (TTOO) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - February 2 at 3:28 AM
T2 Biosystems (TTOO) Coverage Initiated by Analysts at Goldman Sachs GroupT2 Biosystems (TTOO) Coverage Initiated by Analysts at Goldman Sachs Group
www.americanbankingnews.com - January 29 at 6:02 PM
T2 Biosystems (TTOO) Earns "Buy" Rating from HC WainwrightT2 Biosystems (TTOO) Earns "Buy" Rating from HC Wainwright
www.americanbankingnews.com - January 25 at 8:32 AM
-$0.42 EPS Expected for T2 Biosystems Inc (TTOO) This Quarter-$0.42 EPS Expected for T2 Biosystems Inc (TTOO) This Quarter
www.americanbankingnews.com - January 19 at 5:28 AM
Reviewing STAAR Surgical (STAA) & T2 Biosystems (TTOO)Reviewing STAAR Surgical (STAA) & T2 Biosystems (TTOO)
www.americanbankingnews.com - January 11 at 1:10 AM
T2 BIOSYSTEMS, INC. - StreetInsider.comT2 BIOSYSTEMS, INC. - StreetInsider.com
www.streetinsider.com - January 8 at 3:39 PM
T2 Biosystems (TTOO) Offers Prlim. Q4 Results, Provides Update on T2Bacteria PanelT2 Biosystems (TTOO) Offers Prlim. Q4 Results, Provides Update on T2Bacteria Panel
www.streetinsider.com - January 6 at 9:37 AM
Zacks Investment Research Downgrades T2 Biosystems (TTOO) to HoldZacks Investment Research Downgrades T2 Biosystems (TTOO) to Hold
www.americanbankingnews.com - January 6 at 6:32 AM
EARS Down But Not Out, Major Event Awaits AMRN In Q3, Exciting Time For TTOOEARS Down But Not Out, Major Event Awaits AMRN In Q3, Exciting Time For TTOO
www.nasdaq.com - January 5 at 10:52 AM
T2 Biosystems Announces Preliminary Fourth Quarter 2017 Financial Results and Provides Update on T2Bacteria PanelT2 Biosystems Announces Preliminary Fourth Quarter 2017 Financial Results and Provides Update on T2Bacteria Panel
finance.yahoo.com - January 5 at 10:52 AM
T2 Biosystems Inc (TTOO) Expected to Post Quarterly Sales of $1.15 MillionT2 Biosystems Inc (TTOO) Expected to Post Quarterly Sales of $1.15 Million
www.americanbankingnews.com - January 4 at 11:52 AM
T2 Biosystems (TTOO) versus Syneron Medical (ELOS) Head to Head SurveyT2 Biosystems (TTOO) versus Syneron Medical (ELOS) Head to Head Survey
www.americanbankingnews.com - December 31 at 3:28 AM
ETFs with exposure to T2 Biosystems, Inc. : December 26, 2017ETFs with exposure to T2 Biosystems, Inc. : December 26, 2017
finance.yahoo.com - December 26 at 3:12 PM
 Analysts Expect T2 Biosystems Inc (TTOO) Will Post Quarterly Sales of $1.15 Million Analysts Expect T2 Biosystems Inc (TTOO) Will Post Quarterly Sales of $1.15 Million
www.americanbankingnews.com - December 18 at 7:00 AM
T2 Biosystems Inc (TTOO) Expected to Post Earnings of -$0.42 Per ShareT2 Biosystems Inc (TTOO) Expected to Post Earnings of -$0.42 Per Share
www.americanbankingnews.com - December 16 at 5:12 PM
T2 Biosystems Inc (TTOO) Given Consensus Recommendation of "Hold" by AnalystsT2 Biosystems Inc (TTOO) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - December 14 at 3:54 AM
$1.15 Million in Sales Expected for T2 Biosystems Inc (TTOO) This Quarter$1.15 Million in Sales Expected for T2 Biosystems Inc (TTOO) This Quarter
www.americanbankingnews.com - November 30 at 12:06 PM
T2 Biosystems to Attend the Global Mizuho Investor Conference ... - GlobeNewswire (press release)T2 Biosystems to Attend the Global Mizuho Investor Conference ... - GlobeNewswire (press release)
globenewswire.com - November 27 at 3:21 PM
T2 Biosystems to Attend the Global Mizuho Investor ConferenceT2 Biosystems to Attend the Global Mizuho Investor Conference
finance.yahoo.com - November 27 at 9:06 AM
T2 Biosystems Announces New T2Bacteria RUO Panel Data Presented at AMP 2017 - NasdaqT2 Biosystems Announces New T2Bacteria RUO Panel Data Presented at AMP 2017 - Nasdaq
www.nasdaq.com - November 20 at 11:41 AM
T2 Biosystems Announces New T2Bacteria RUO Panel Data Presented at AMP 2017T2 Biosystems Announces New T2Bacteria RUO Panel Data Presented at AMP 2017
finance.yahoo.com - November 20 at 11:41 AM
T2 Biosystems, Inc. (TTOO) Receives Average Recommendation of "Hold" from AnalystsT2 Biosystems, Inc. (TTOO) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - November 19 at 4:02 AM
Zacks: Brokerages Expect T2 Biosystems, Inc. (TTOO) Will Post Quarterly Sales of $1.15 MillionZacks: Brokerages Expect T2 Biosystems, Inc. (TTOO) Will Post Quarterly Sales of $1.15 Million
www.americanbankingnews.com - November 11 at 2:32 AM
 Analysts Expect T2 Biosystems, Inc. (TTOO) Will Post Earnings of -$0.43 Per Share Analysts Expect T2 Biosystems, Inc. (TTOO) Will Post Earnings of -$0.43 Per Share
www.americanbankingnews.com - November 9 at 7:15 PM
T2 Biosystems Announces Presentation on T2Sepsis Solution at AMP 2017 - GlobeNewswire (press release)T2 Biosystems Announces Presentation on T2Sepsis Solution at AMP 2017 - GlobeNewswire (press release)
globenewswire.com - November 9 at 8:48 AM
ETFs with exposure to T2 Biosystems, Inc. : November 8, 2017ETFs with exposure to T2 Biosystems, Inc. : November 8, 2017
finance.yahoo.com - November 9 at 8:48 AM
T2 Biosystems Announces Presentation on T2Sepsis Solution at AMP 2017T2 Biosystems Announces Presentation on T2Sepsis Solution at AMP 2017
finance.yahoo.com - November 9 at 8:48 AM
T2 Biosystems, Inc. :TTOO-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017T2 Biosystems, Inc. :TTOO-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017
finance.yahoo.com - November 7 at 12:35 PM
HC Wainwright Reaffirms Buy Rating for T2 Biosystems, Inc. (TTOO)HC Wainwright Reaffirms Buy Rating for T2 Biosystems, Inc. (TTOO)
www.americanbankingnews.com - November 5 at 6:20 PM
T2 Biosystems, Inc. to Host Earnings CallT2 Biosystems, Inc. to Host Earnings Call
finance.yahoo.com - November 5 at 7:42 AM
T2 Biosystems Reports Third Quarter 2017 Financial Results and Provides Company UpdateT2 Biosystems Reports Third Quarter 2017 Financial Results and Provides Company Update
finance.yahoo.com - November 5 at 7:42 AM
T2 Biosystems reports 3Q lossT2 Biosystems reports 3Q loss
finance.yahoo.com - November 5 at 7:42 AM
Edited Transcript of TTOO earnings conference call or presentation 2-Nov-17 8:30pm GMTEdited Transcript of TTOO earnings conference call or presentation 2-Nov-17 8:30pm GMT
finance.yahoo.com - November 5 at 7:42 AM
T2 Biosystems, Inc. (TTOO) Issues Quarterly  Earnings Results, Beats Expectations By $0.04 EPST2 Biosystems, Inc. (TTOO) Issues Quarterly Earnings Results, Beats Expectations By $0.04 EPS
www.americanbankingnews.com - November 3 at 3:22 PM
T2 Biosystems to Attend the Canaccord Medical Technologies and Diagnostics Forum - GlobeNewswire (press release)T2 Biosystems to Attend the Canaccord Medical Technologies and Diagnostics Forum - GlobeNewswire (press release)
globenewswire.com - November 1 at 9:59 AM
T2 Biosystems to Attend the Canaccord Medical Technologies and Diagnostics ForumT2 Biosystems to Attend the Canaccord Medical Technologies and Diagnostics Forum
finance.yahoo.com - November 1 at 9:58 AM
T2 Biosystems, Inc. (TTOO) Receives Average Recommendation of "Hold" from BrokeragesT2 Biosystems, Inc. (TTOO) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - October 25 at 5:02 AM
T2 Biosystems, Inc. (TTOO) Expected to Announce Quarterly Sales of $1.09 MillionT2 Biosystems, Inc. (TTOO) Expected to Announce Quarterly Sales of $1.09 Million
www.americanbankingnews.com - October 23 at 1:24 PM
T2 Biosystems, Inc. (TTOO) Scheduled to Post Quarterly Earnings on MondayT2 Biosystems, Inc. (TTOO) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - October 23 at 11:18 AM
-$0.48 Earnings Per Share Expected for T2 Biosystems, Inc. (TTOO) This Quarter-$0.48 Earnings Per Share Expected for T2 Biosystems, Inc. (TTOO) This Quarter
www.americanbankingnews.com - October 21 at 2:22 AM
T2 Biosystems Announces 2017 Third Quarter Financial and Operational Results Release and Conference Call DateT2 Biosystems Announces 2017 Third Quarter Financial and Operational Results Release and Conference Call Date
finance.yahoo.com - October 17 at 8:25 AM
ETFs with exposure to T2 Biosystems, Inc. : October 13, 2017ETFs with exposure to T2 Biosystems, Inc. : October 13, 2017
finance.yahoo.com - October 14 at 8:51 AM

SEC Filings

T2 Biosystems (NASDAQ:TTOO) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

T2 Biosystems (NASDAQ:TTOO) Income Statement, Balance Sheet and Cash Flow Statement

Chart

T2 Biosystems (NASDAQ TTOO) Stock Chart for Thursday, February, 22, 2018

Loading chart…

This page was last updated on 2/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.